PBPK modeling

0:00:54

GastroPlus® Workshop: Physiologically Based Pharmacokinetic Modeling for FIH Predictions

0:15:48

Using PBPK Absorption Modeling to Support Biopharmaceutics Classification System Class 3 Drug Waiver

1:17:25

GastroPlus® “Workshop from Home” April 17 PBPK PD modeling course with Haiying Zhou

0:30:46

Physiologically based pharmacokinetic modeling for the simulation of relevant clinical scenarios

1:28:00

Applying MAM PBPK Modeling to Predict Positive Negative Food Effects

0:53:33

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

0:59:17

Strategic Application of PBPK Models for Predicting DDIs & the Effects of Smoking & Organ Impairment

0:54:15

PBPK modeling of Distinct Change in OATP1B Substrate Pharmacokinetics during OATP1B-Mediated DDIs

0:49:01

Next Gen Tech for QST/QSP & PBPK Modeling

0:54:40

PBPK and QSP model implementation and utilization in R (Part 1)

0:00:53

Application-Based Drug Discovery Workshop: Drug Design… Meet PBPK

0:36:18

Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)

0:19:14

IVIVE-PBPK Modeling for Inhalation Toxicity Testing

0:38:36

Getting at the HAART of Precision Dosing: Using PBPK Models to Optimize Dosing of an Antiviral

0:02:12

a prototype of PBPK modeling & simulation

0:19:43

A Physiologically Based Pharmacokinetic Model to Predict the Superparamagnetic Iron Oxide...

1:05:05

Utilization of PBBM/PBPK Models for Building a Safe Space and Regulatory Applications in Support of

0:47:14

PML School: Minimal Physiologically-based Pharmacokinetic Model for Monoclonal Antibodies (mAbs)

0:17:03

Adding OATP and MRP-2 transporters to PBPK models in GastroPlus™

0:56:08

QSP & Simcyp Designer: Seamless & User-Friendly Integration of QSP and PBPK Models

0:58:19

2023 August - Proteomics Informed PBPK Modeling to Predict Systemic and Tissue Drug Concentrations

1:11:24

ADMET Predictor 8.5 Webinar: ‘Discovery PBPK’ Efficiently use PBPK modeling to drive lead selection

0:00:17

Regulatory utility of physiologically based pharmacokinetic modeling for assessing fo... | RTCL.TV

0:15:03

Physiological Pharmacokinetic Model / PBPK Model / L-4 Unit-3 Biopharmaceutics